The Global Mosaic Variegated Aneuploidy (MVA) Syndrome Treatment Market is poised for significant expansion. Valued at USD 31.15 million in 2024, the market is projected to reach USD 98.76 million by 2032, growing at a compound annual growth rate (CAGR) of 16.60% from 2025 to 2032. This article provides a comprehensive analysis of market dynamics, segmentation, drivers, challenges,...